Evidence map›Paper›PMID 41626556›Full record

ArticleFrontiers in systems biology2025

A synthetic biology toolkit for rationally designing genetic circuits in

Sara Letrari, Lisa Faccincani, Stefano Intini, Ilgin Ertan, Tommaso Varaschin, Francesca Galiazzo, Marco Costanzo, Giorgia D'angelo, Valentina Del Giudice, Luca Guarnieri and 10 more

Abstract read
In one paragraph

Article in Frontiers in systems biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sara LetrariUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Lisa FaccincaniDepartment Information Engineering, University of Padova, Padova, Italy.
Stefano IntiniDepartment Molecular Medicine, University of Padova, Padova, Italy.
Ilgin ErtanDepartment Molecular Medicine, University of Padova, Padova, Italy.
Tommaso VaraschinUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Francesca GaliazzoUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Marco CostanzoUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Giorgia D'angeloUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Valentina Del GiudiceUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Luca GuarnieriUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Alex MartiniUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Asia PicchiUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Chiara RavazzoloUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Niccolò Venturini Degli EspostiUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Chiara ZaninUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Livio TrainottiUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Cristiano De PittàUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Claudia Del VecchioUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.
Ignazio CastagliuoloDepartment Molecular Medicine, University of Padova, Padova, Italy.
Massimo BellatoUniPadua-IT 2023 iGEM Team, University of Padova, Padova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antimicrobial resistance (AMR) poses a severe global health threat, with Methods: To combat AMR through synthetic biology, this study characterizes a library of BioBrick parts to be adopted in Results: Key components were characterized, including two plasmid vectors, a library of inducible and constitutive promoters, and a CRISPRi-mediated repression system; for the latter, a testbed for biofilm-related genes implicated in the downregulation of antibiotic resistance is also provided. Discussion: By enabling tunable transcriptional control through the characterized promoters and ensuring the ability to downregulate gene expression via CRISPRi, this synthetic biology toolkit lays the foundation for the rational design of genetic circuits to study and counteract AMR in

Indexed as

Acinetobacter baumanniiBioBrickCRISPRigene expressiongenetic circuitsynthetic and systems biology

Identifiers

PMID41626556
PMCPMC12852451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.